ZURA BIO LIMITED

Analyst Reco. Zura Bio Limited

Equities

ZURA

KYG9TY5A1016

End-of-day quote Nasdaq Other stock markets 06:00:00 2024-06-13 pm EDT			5-day change	1st Jan Change
3.77 ^USD	+1.07%		-5.99%	-19.27%

Jun. 06	Zura Bio Limited Announces Formation of a Scientific Advisory Board	CI
Jun. 03	Zura Bio Limited to Present Data Exploring the Expanded Potential of Tibulizumab Into Sjogren's Syndrome and Rheumatoid Arthritis at EULAR 2024	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Zura Bio Insider Bought Shares Worth $496,000, According to a Recent SEC Filing	May. 23	MT
Oppenheimer Adjusts Zura Bio Price Target to $21 From $16, Maintains Outperform Rating	May. 10	MT
Piper Sandler Starts Zura Bio With Overweight Rating, $26 Price Target	May. 03	MT
Zura Bio Insider Bought Shares Worth $499,999, According to a Recent SEC Filing	Apr. 25	MT
Zura Bio Insider Bought Shares Worth $3,715,000, According to a Recent SEC Filing	Apr. 25	MT
Oppenheimer Adjusts Zura Bio Price Target to $16 From $17, Maintains Outperform Rating	Apr. 01	MT
Ladenburg Thalmann Starts Zura Bio With Buy Rating, $10 Price Target	23-10-10	MT
Oppenheimer Initiates Coverage on Zura Bio With Outperform Rating, $17 Price Target	23-08-25	MT
Raymond James Adjusts Price Target on Zura Bio to $22 From $20, Keeps Strong Buy Rating	23-08-15	MT
Guggenheim Initiates Zura Bio at Buy With $20 Price Target	23-06-22	MT
Chardan Initiates Zura Bio at Buy With $14 Price Target	23-06-14	MT
Raymond James Starts Zura Bio at Strong Buy With $20 Price Target	23-05-24	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer